4//SEC Filing
Dekker C. Jeffrey 4
Accession 0001209191-22-060497
CIK 0000907654other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 4:30 PM ET
Size
8.8 KB
Accession
0001209191-22-060497
Insider Transaction Report
Form 4
Dekker C. Jeffrey
Chief Financial Officer
Transactions
- Award
Common Stock
2022-12-08+40,000→ 40,000 total
Footnotes (1)
- [F1]Represents shares issued as restricted stock units (an "RSU") under the Issuer's 2020 Equity Incentive Plan (the "2020 Plan"). The RSUs vest one year from December 8, 2022, subject to continuing employment with the Company through that date. In the event of a change in control of the Issuer or the grantee's involuntary termination without cause or by the grantee for good reason, 100% of the unvested RSUs shall become fully and immediately vested upon the closing date of such change in control or such involuntary termination date, respectively (to the extent such unvested RSUs have not yet then vested).
Documents
Issuer
ARCA biopharma, Inc.
CIK 0000907654
Entity typeother
Related Parties
1- filerCIK 0001546840
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 4:30 PM ET
- Size
- 8.8 KB